<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">Colorectal cancers</z:e> diagnosed in the interval after a complete colonoscopy may occur due to rapid <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Interval <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> are associated with microsatellite instability (MSI) </plain></SENT>
<SENT sid="2" pm="."><plain>AIMS: Our aim was to study the association of KRAS mutation with interval <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> and MSI </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We searched our institution's <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registry for interval <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e>, defined as <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> that developed within 5 years of a complete colonoscopy </plain></SENT>
<SENT sid="4" pm="."><plain>These were frequency matched to patients with non-interval <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Archived <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> specimens were evaluated for KRAS mutations in codons 12 and 13 using sequencing, and MSI by sequencing microsatellite loci </plain></SENT>
<SENT sid="6" pm="."><plain>Multivariable logistic regression was used to analyze the association between KRAS mutation status, MSI status and interval <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: There were 63 interval and 131 non-interval <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>KRAS mutation was present in 12.9% of interval <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> compared to 28.9% of non-interval <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (P = 0.03) </plain></SENT>
<SENT sid="9" pm="."><plain>In multivariable logistic regression model, KRAS was inversely associated with interval <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (OR 0.36; 95% CI 0.15-0.90) </plain></SENT>
<SENT sid="10" pm="."><plain>In Cox proportional hazards model, adjusting for age, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> grade, TNM Stage and MSI status, we found no association between KRAS mutation and 5-year survival compared to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> without KRAS mutation (HR 0.84; 95% CI 0.4-1.46; P = 0.5) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: KRAS mutation is inversely associated with interval <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and with MSI, suggesting that it is a marker of the <z:mp ids='MP_0008866'>chromosomal instability</z:mp> pathway associated with slow <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e>, and distinct from MSI rapidly growing <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Molecular characterization of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> is helpful in determining underlying pathway and may determine therapy </plain></SENT>
</text></document>